Revvity Inc.

NYSE: RVTY · Real-Time Price · USD
92.00
-0.83 (-0.89%)
At close: May 05, 2025, 3:59 PM
-0.89%
Bid 91.11
Market Cap 11.05B
Revenue (ttm) 2.77B
Net Income (ttm) 309.38M
EPS (ttm) 2.42
PE Ratio (ttm) 38.02
Forward PE 17.12
Analyst Buy
Ask 98.66
Volume 14,431
Avg. Volume (20D) 1,211,143
Open 91.89
Previous Close 92.83
Day's Range 91.40 - 92.53
52-Week Range 88.53 - 129.50
Beta 1.02

About RVTY

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences resea...

Sector Healthcare
IPO Date Jul 6, 1965
Employees 11,000
Stock Exchange NYSE
Ticker Symbol RVTY
Full Company Profile

Analyst Forecast

According to 13 analyst ratings, the average rating for RVTY stock is "Buy." The 12-month stock price forecast is $125, which is an increase of 35.87% from the latest price.

Stock Forecasts

Earnings Surprise

Revvity has released their quartely earnings on Apr 28, 2025:
  • Revenue of $664.76M exceeds estimates by $3.58M, with 2.28% YoY growth.
  • EPS of 1.01 exceeds estimates by 0.06, with 3.06% YoY growth.
  • 1 week ago
    +0.82%
    RVTY stock has given up its prior gain. Revvity sh... Unlock content with Pro Subscription
    1 week ago
    +0.82%
    Revvity shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance with its midpoint above estimates.